Oculis Holding AG (OCS) Tax Rate Growth (1y) (2023 - 2026)

Oculis Holding AG (OCS) Tax Rate Growth (1y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Revolution Medicines 37.28 Bn 37.28 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -36.00
Dec 31, 2025 34,609.00
Sep 30, 2025 -1.00
Jun 30, 2025 -24.00
Mar 31, 2025 -17.00
Dec 31, 2024 -72.00
Sep 30, 2024 75.00
Jun 30, 2024 -75.00
Mar 31, 2024 -8.00
Dec 31, 2023 5.00
Sep 30, 2023 -72.00
Jun 30, 2023 55.00